SCHEMBL8036847

SCHEMBL8036847

C=C(C)N(CC)C(=O)/C=C/CN(C)C

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21443474 1.00 BTK (0.30) BTKCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL20381564 0.86 RXRA (0.32)
SCHEMBL9069815 0.86 RXRA (0.32)
SCHEMBL11932207 0.81 RXRA (0.31)
SCHEMBL18469903 0.81 RXRA (0.31)
SCHEMBL18431820 0.81 CHRNB2 (0.34) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL12518465 0.75 NPC1 (0.43) BTKCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL14959224 0.75 CHRNB2 (0.34) BTKCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19820321 0.74
SCHEMBL12519507 0.72 CHRNB2 (0.52) BTKCHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012122383-A2 PI3 KINASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2012-09-13 WO disclosed
WO-2011090760-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-07-28 WO disclosed
WO-2009082701-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2009-07-02 WO disclosed